Movement Alert｜Synopsys Falls 3.17% in Regular Trading, Shares Pull Back Despite Recent Analyst Target Increases

Market Focus10-22 22:01

On October 22, Synopsys fell 3.17% in Regular Trading, trading at $438.505 per share, with turnover of $74.996 million.

The most recent relevant development was a Morgan Stanley price-target increase on October 20 to $574 from $500. Earlier in the month, Needham raised its target to $620 from $580, and KeyBanc lifted its target to $605 while maintaining an overweight-equivalent stance. Synopsys had also announced a $1 billion accelerated share repurchase agreement and previously outlined fiscal 2027 targets including about $11.15 billion in revenue at the midpoint and roughly $3.1 billion in free cash flow. Even so, the stock moved lower in the current session, indicating the recent supportive analyst actions and capital return plan did not prevent near-term selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment